GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 678 filers reported holding GLAXOSMITHKLINE PLC in Q4 2013. The put-call ratio across all filers is 0.49 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2017 | $483,000 | -5.8% | 11,900 | 0.0% | 0.51% | -11.1% |
| Q2 2017 | $513,000 | -7.1% | 11,900 | -9.2% | 0.57% | -0.2% |
| Q1 2017 | $552,000 | -5.2% | 13,100 | -13.2% | 0.57% | -10.7% |
| Q4 2016 | $582,000 | -16.1% | 15,100 | -6.2% | 0.64% | -8.1% |
| Q3 2016 | $694,000 | +17.2% | 16,100 | +17.9% | 0.69% | +2.2% |
| Q2 2016 | $592,000 | -0.7% | 13,650 | -7.1% | 0.68% | -9.0% |
| Q1 2016 | $596,000 | -6.3% | 14,700 | -6.7% | 0.75% | +9.4% |
| Q4 2015 | $636,000 | +14.0% | 15,750 | +8.6% | 0.68% | +9.8% |
| Q3 2015 | $558,000 | 0.0% | 14,500 | +8.2% | 0.62% | +26.7% |
| Q2 2015 | $558,000 | -10.4% | 13,400 | -0.7% | 0.49% | -6.1% |
| Q1 2015 | $623,000 | +8.0% | 13,500 | 0.0% | 0.52% | +5.5% |
| Q4 2014 | $577,000 | -5.3% | 13,500 | +1.9% | 0.50% | -3.9% |
| Q3 2014 | $609,000 | -14.1% | 13,250 | 0.0% | 0.52% | +3.2% |
| Q2 2014 | $709,000 | -2.5% | 13,250 | -2.6% | 0.50% | -2.2% |
| Q1 2014 | $727,000 | -11.0% | 13,600 | -11.1% | 0.51% | -7.4% |
| Q4 2013 | $817,000 | +6.4% | 15,300 | 0.0% | 0.55% | -0.2% |
| Q3 2013 | $768,000 | -5.8% | 15,300 | -6.1% | 0.55% | -14.7% |
| Q2 2013 | $815,000 | – | 16,300 | – | 0.65% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| KAHN BROTHERS GROUP INC | 1,282,289 | $46,483,403 | 7.25% |
| Columbia Asset Management | 9,960 | $361 | 0.08% |
| PARK CIRCLE Co | 800 | $29,000 | 0.03% |
| PARADIGM ASSET MANAGEMENT CO LLC | 1,800 | $65,250 | 0.02% |
| Byrne Asset Management LLC | 56 | $2,000 | 0.00% |
| Retirement Group, LLC | 40 | $1,450 | 0.00% |
| Bartlett & Co. LLC | 240 | $9 | 0.00% |
| HUNTINGTON NATIONAL BANK | 1 | $40 | 0.00% |